High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

NCT01266603 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: HDIL-2
BIOLOGICAL: recMAGE-A3 + AS15

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]